{"bill":{"id":"118-hr-7384","congress":118,"type":"HR","number":7384,"title":"Creating Hope Reauthorization Act of 2024","originChamber":"House","introducedDate":"2024-02-15","sponsors":[{"bioguideId":"M001157","fullName":"Rep. McCaul, Michael T. [R-TX-10]","party":"R","state":"TX","district":10}],"cosponsorsCount":66,"latestAction":{"actionDate":"2024-02-16","text":"Referred to the Subcommittee on Health."},"policyArea":"Health","subjects":["Child health","Drug safety, medical device, and laboratory regulation","Prescription drugs"],"actions":[{"date":"2024-02-16","text":"Referred to the Subcommittee on Health.","type":"Committee","chamber":"House committee actions","hasVote":false},{"date":"2024-02-15","text":"Referred to the House Committee on Energy and Commerce.","type":"IntroReferral","chamber":"House floor actions","hasVote":false},{"date":"2024-02-15","text":"Introduced in House","type":"IntroReferral","chamber":"Library of Congress","hasVote":false},{"date":"2024-02-15","text":"Introduced in House","type":"IntroReferral","chamber":"Library of Congress","hasVote":false}],"summary":" <p><b>Creating Hope Reauthorization Act</b> <b>of 2024</b></p> <p>This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)</p>","updateDate":"2025-05-27T14:13:57Z"},"markets":[],"stateBills":[],"meta":{"sources":["congress.gov"],"latencyMs":334,"ts":"2026-04-19T09:58:40.977Z"},"nextActions":{"inspect":[],"related":[{"description":"Search related legislation","method":"GET","url":"/api/public/query-gov?q=Creating%20Hope%20Reauthorization%20Act%20of%202024"}]}}